Article
Macrophage cell therapy enabled by interleukin-4 mRNA-loaded lipid nanoparticles to sustain a pro-reparative phenotype in inflammatory injuries.
Biomaterials - 1 May 2026
O'Brien Erin M, Tylek Tina, Geisler Hannah C, Mukalel Alvin J, Whitaker Ricardo C, Sung Samuel, Binder-Markey Benjamin I, Weissman Drew, Mitchell Michael J, Spiller Kara L
Abstract excerpt
The use of macrophage cell therapies is limited by their tendency to change phenotype in response to external cues in situ. Here we demonstrate that an optimized lipid nanoparticle (LNP) formulation effectively delivers IL4 mRNA to human and murine primary macrophages, resulting in rapid transfection, IL-4 secretion, and reparative phenotype modulation. In a model of murine volumetric muscle loss, adoptively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
